Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebellar-cortical Circuitry and Prediction of Treatment Response in Early Psychosis
NCT07483294Phase 4Recruiting
- Sponsor
- Northwell Health
- Start
- Nov 2025
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risperidone, aripiprazole in psychosis, sponsored by Northwell Health. Started Nov 2025; status: recruiting.
02
Drugs
risperidonearipiprazole
03
Conditions
psychosis
Beyond the preview
Go deeper on NCT07483294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07483294.